Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Organizational AI use grows eightfold, yet governance gap remains: survey
-
Fortuna reports third quarter 2026 production of 69,665 gold equivalent ounces and advances key growth initiatives
-
Clear Street Partners with Seawolf Capital to Bring Strategic Markets Content and Events to the Investing Community
-
ITM and Lumara Bio to Announce New Data for ¹⁷⁷Lu-edotreotide (ITM-11) and Ga-DPI-4452 at EANM 2026
-
MUVON Therapeutics Reports Positive 12-Month Phase 2 Follow-up Data Confirming Durable Efficacy of its First-in-Class Muscle Regeneration Therapy in Stress Urinary Incontinence
-
Dimensional Fund Advisors Ltd. : Form 8.3 - TATE & LYLE PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - SPIRE HEALTHCARE GROUP PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - PROLOGIS INC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - PHAROS ENERGY PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - CAPRICORN ENERGY PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - ADVANCED MEDICAL SOLUTIONS - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DCC Energy PLC - Ordinary Shares
-
Result of the auction of 2.00 per cent DGB 2028 and 2.25 per cent DGB 2035
-
Deutsche Lufthansa AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 06 10 2026] - (CGWL)
-
Real machining challenges take centre stage for Dormer Pramet at AMB 2026
-
Securonix Named to 2026 Fortune Future 120 for Long-Term Growth Potential
-
BIO-Europe C-Suite Survey: Biopharma dealmaking set to accelerate, but investor caution still caps ambition
-
Virbac : Declaration of the number of shares et voting rights 09/2026
-
Holding(s) in Company
-
BDC expands partnerships to help defence companies access opportunities and scale
-
Percona Announces Valkey-proxy, an Open Source Project to Ease Enterprise Migration to Valkey
-
FTI Consulting Expands Technology Transformation Capabilities in EMEA With Appointment of Anita Fuller
-
PulseSight presents PST-611 Phase I new early clinical efficacy data at EURETINA, offering a potential breakthrough approach to treat Dry AMD/Geographic Atrophy
-
Notice of GM
-
Transactions with shares in AL Sydbank by managers and closely associated persons
-
NNIT A/S: Process for potential divestment of SCALES A/S
-
Proposals to the Extraordinary General Meeting of Aspo Plc: Composition of the future Boards of Directors of ESL Shipping Group Plc and Telko Group Plc (currently Aspo Plc)
-
INVL fund sold 2,600 hectares of forests in Latvia
-
Bekaert - Publication transparency notification
-
Syncron Launches Service Contract Performance to Help OEMs Grow Profitable Service Revenue
-
Juniper Research Unveils Identity & Security Award Winners for 2026
-
VAALCO Energy, Inc. Announces Positive Operational Updates
-
Sereact, Zalando and CEVA Logistics start AI-powered, automated returns handling in Germany and Poland
-
125,000 Orion Corporation A shares converted into B shares
-
From investments to cash flow
-
Shell third quarter 2026 update note
-
Transaction in Own Shares
-
Unaudited Interim Results for the six months ended 31 July 2026
-
NBPE Announces Transaction in Own Shares
-
Net Asset Value
-
Juniper Research Unveils Identity & Security Award Winners for 2026
-
Cancellation of Treasury Shares
-
Oculis to Highlight Licaminlimab at Eyecelerator @ AAO 2026 and Partner with Neuro-Ophthalmology Subspecialty Day
-
Xeris Technologies Completes Major Security and Infrastructure Phase Ahead of Mainnet
-
Nurix Therapeutics Announces First Patient Enrolled in Phase 1b/2 Combination Study of Bexobrutideg in Chronic Lymphocytic Leukemia
-
Start of Day Message
-
Elis announces the results of the conversion and exchange period for its 2029 OCEANEs
-
Hotel Blacklist Launches New Accommodation Industry Risk Assessment Tool
-
Vaxcyte Announces Pricing of Concurrent Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes


